Pecaset 150 mg & 500 mg Tablet

Pecaset 150 mg & 500 mg Tablet

S4
PDF Leaflet Revision Date: 22 April 2025

API: Capecitabine | Company: Eurolab

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of metastatic breast, colorectal, and gastric cancer.

Dosage (summary)

1,250 mg/mu00b2 twice daily for 14 days, followed by 7 days rest; adjust for renal impairment.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation due to potential risks.

Key Drug Interactions

  • Warfarin
  • Sorivudine
  • Phenytoin
  • Leucovorin

Contraindications

  • Hypersensitivity to capecitabine
  • Severe renal impairment
  • Severe hepatic impairment
  • DPD deficiency

Common side effects

  • Diarrhoea
  • Nausea
  • Neutropenia
  • Fatigue
  • Palmar-plantar erythrodysaesthesia

Counselling Points

  • Take with water within 30 mins after meals.
  • Report any signs of severe toxicity immediately.
  • Use effective contraception during treatment.

Serious warnings

  • Monitor for severe toxicity
  • Risk of coagulopathy with anticoagulants
  • Potential for cardiotoxicity

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Pecaset 150 mg & 500 mg Tablet
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW